Overview
LL-37 is a human cathelicidin research peptide studied in innate immunity, host-defense, and membrane-interaction pathway models. It is supplied as lyophilized powder in a 5 mg presentation for laboratory research workflows only.

LL-37 is a human cathelicidin research peptide studied in innate immunity, host-defense, and membrane-interaction pathway models. It is supplied as lyophilized powder in a 5 mg presentation for laboratory research workflows only.
LL-37 is a human cathelicidin research peptide studied in innate immunity, host-defense, and membrane-interaction pathway models. It is supplied as lyophilized powder in a 5 mg presentation for laboratory research workflows only.
Batch LL029-240626 is linked to product specifications and analytical documentation.
Open certificate library →| Molecular Formula | C205H340N60O53 |
|---|---|
| Molecular Weight | 4492.3 g/mol |
| Sequence | Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser |
| Product Form | Lyophilized Powder |
| Presentation | 5 mg / 10 Vials |
| Batch Number | LL029-240626 |
| Testing | HPLC purity verification; third-party COA recommended for final release |
| Appearance | White to off-white lyophilized powder |
| Storage | Store according to batch COA and internal laboratory SOP. Protect from light and avoid repeated freeze-thaw cycles where applicable. |
| Research Use | For laboratory Research Use Only (RUO). |